Agilent Technologies (A) Stock Forecast & Price Target $115.01 +0.22 (+0.19%) Closing price 05/22/2026 03:59 PM EasternExtended Trading$114.22 -0.79 (-0.69%) As of 05/22/2026 06:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Agilent Technologies - Analysts' Recommendations and Stock Price Forecast (2026) How MarketBeat Calculates Price Target and Consensus Rating Consensus Rating BuyBased on 15 Analyst RatingsSell0Hold2Buy13 Based on 15 Wall Street analysts who have issued ratings for Agilent Technologies in the last 12 months, the stock has a consensus rating of "Buy." Out of the 15 analysts, 2 have given a hold rating, 11 have given a buy rating, and 2 have given a strong buy rating for A. Consensus Price Target $163.7142.35% Upside According to the 15 analysts' twelve-month price targets for Agilent Technologies, the average price target is $163.71. The highest price target for A is $185.00, while the lowest price target for A is $135.00. The average price target represents a forecasted upside of 42.35% from the current price of $115.01. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Get the Latest News and Ratings for A and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Agilent Technologies and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. A Analyst Ratings Over TimeTypeCurrent Forecast5/23/25 to 5/23/261 Month Ago4/23/25 to 4/23/263 Months Ago2/22/25 to 2/22/261 Year Ago5/23/24 to 5/23/25Strong Buy2 Strong Buy rating(s)2 Strong Buy rating(s)2 Strong Buy rating(s)0 Strong Buy rating(s)Buy11 Buy rating(s)11 Buy rating(s)11 Buy rating(s)6 Buy rating(s)Hold2 Hold rating(s)2 Hold rating(s)3 Hold rating(s)7 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$163.71$163.71$164.50$141.42Forecasted Upside42.35% Upside43.20% Upside33.82% Upside30.20% UpsideConsensus RatingBuyBuyModerate BuyHold A Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History A Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table Agilent Technologies Stock vs. The CompetitionTypeAgilent TechnologiesMedical CompaniesBroader MarketConsensus Rating Score 3.00 2.30 2.52Consensus RatingBuyHoldModerate BuyPredicted Upside42.35% Upside1,714.95% Upside15.10% UpsideNews Sentiment RatingNeutral NewsSee Recent A NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export DateBrokerageAnalystActionRatingPrice TargetReport Date Upside/DownsideDetails4/14/2026 Barclays3 of 5 starsLuke Sergott4 of 5 starsLower TargetOverweight$150.00 ➝ $140.00+16.28%3/3/2026 Morgan Stanley3 of 5 starsKallum TitchmarshNot RatedLower TargetOverweight$180.00 ➝ $160.00+38.13%2/26/2026 UBS Group4 of 5 starsDan Leonard3 of 5 starsLower TargetBuy$180.00 ➝ $165.00+38.94%2/26/2026 TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDan BrennanSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetBuy$170.00 ➝ $157.00+36.12%2/26/2026 Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBrandon CouillardSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetOverweight$175.00 ➝ $165.00+40.85%1/20/2026 HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeStrong-Buy1/5/2026 EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingVijay KumarSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingUpgradeIn-Line ➝ Outperform$155.00 ➝ $160.00+16.09%12/29/2025 Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingHold (C+)12/9/2025 The Goldman Sachs GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingEvie KosloskySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingInitiated CoverageBuy$170.00+19.43%11/25/2025 CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPatrick DonnellySubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetBuy$165.00 ➝ $185.00+17.40% Get the Latest News and Ratings for A and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter. 11/25/2025 JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCasey WoodringSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOverweight$165.00 ➝ $180.00+15.53%11/25/2025 Robert W. BairdSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingCatherine SchulteSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetOutperform$142.00 ➝ $165.00+7.68%11/25/2025 Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDerik DeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingBoost TargetNeutral$150.00 ➝ $165.00+7.68%10/8/2025 Rothschild & Co RedburnSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating UpgradeStrong-Buy5/30/2025 Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Boost TargetBuy$135.00+19.78%4/21/2025 Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBrandon CouillardSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingLower TargetHold$135.00 ➝ $116.00+16.44%11/26/2024 Sanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Lower TargetMarket Perform$140.00 ➝ $135.00+1.41%8/26/2024 Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating Reiterated RatingBuy$151.00+7.19%6/27/2024 Wolfe ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDoug SchenkelSubscribe to MarketBeat All Access for the analyst's recommendation accuracy ratingDowngradeOutperform ➝ Peer PerformAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:26 PM ET. Should I Buy Agilent Technologies Stock? A Pros and Cons Explained These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, May 17, 2026. Please send any questions or comments about these Agilent Technologies pros and cons to contact@marketbeat.com. Agilent Technologies Bull Case Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.: The current stock price is around $114.84, which may present a buying opportunity for investors looking for growth in the medical research sector. Agilent Technologies, Inc. reported a revenue increase of 7.0% compared to the same quarter last year, indicating strong business performance and potential for future growth. The company has a solid return on equity of 24.49%, suggesting effective management and profitability, which can be attractive to investors seeking reliable returns. Agilent Technologies, Inc. has a consistent dividend payout, with a recent quarterly dividend of $0.255, translating to an annualized yield of 0.9%, providing income to shareholders. Analysts have a consensus rating of "Buy" for the stock, with a price target of approximately $163.71, indicating potential upside for investors. Agilent Technologies Bear Case Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons: The company recently missed earnings expectations, reporting $1.36 EPS compared to the consensus estimate of $1.37, which may raise concerns about its short-term performance. Agilent Technologies, Inc. has seen its stock price decline from a 12-month high of $160.27, which could indicate a downward trend that investors should be cautious of. The company has a relatively high P/E ratio of 25.35, which may suggest that the stock is overvalued compared to its earnings, potentially deterring value-focused investors. With a beta of 1.30, the stock is more volatile than the market, which could pose risks for investors who prefer stable investments. Recent analyst downgrades have seen price targets reduced significantly, which may reflect a more cautious outlook on the company's future performance. A Forecast - Frequently Asked Questions What is Agilent Technologies' forecast for 2026? According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Agilent Technologies is $163.71, with a high forecast of $185.00 and a low forecast of $135.00. Should I buy or sell Agilent Technologies stock right now? 15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last twelve months. There are currently 2 hold ratings, 11 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" A shares. Does Agilent Technologies's stock price have much upside? According to analysts, Agilent Technologies's stock has a predicted upside of 42.35% based on their 12-month stock forecasts. What analysts cover Agilent Technologies? Agilent Technologies has been rated by research analysts at Barclays, Morgan Stanley, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days. Do Wall Street analysts like Agilent Technologies more than its competitors? Analysts like Agilent Technologies more than other "medical" companies. The consensus rating for Agilent Technologies is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how A compares to other companies. Stock Forecasts and Research Tools Related Companies AMAT Stock Forecast ASUR Stock Forecast GOOGL Stock Forecast SMTC Stock Forecast AME Stock Forecast ANET Stock Forecast DOCN Stock Forecast MTD Stock Forecast TMO Stock Forecast WAT Stock Forecast Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Brokerages With Agilent Technologies RecommendationsWall Street ZenBarclaysMorgan StanleyWells Fargo & CompanyUBS GroupTD CowenHSBCEvercoreWeiss RatingsThe Goldman Sachs GroupJPMorgan Chase & Co.Robert W. BairdCitigroupBank of AmericaRothschild & Co Redburn This page (NYSE:A) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX just filed. The clock is ticking.Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agilent Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agilent Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
